As key cells involved in pro-tumour angiogenesis, HSCs have been demonstrated to upregulate fibroblast activation protein alpha (FAPα) and increase CXCL5 secretion, as regulated by cancer cell-secreted fibroblast growth factor-binding protein 1 (FGFBP1). The gene discussed is FGFBP1; the disease is cancer.